NIMACIMAB

UNII:	85TS31SOL3
Formula:
Preferred Substance Name:	NIMACIMAB
GSRS Full Record:	85TS31SOL3 i

2098636-09-8
IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN CANNABINOID RECEPTOR 1) (HUMAN-MUS MUSCULUS MONOCLONAL RYI-018 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RYI-018 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CANNABINOID RECEPTOR 1)HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.4 HEAVY CHAIN (1-444) (HOMO SAPIENS VH (IGHV1-69*08 (88%) (IGHD)-IGHJ3*01 (91%)) (8.8.10) (1-107)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(225))) (108-444)) (131-215')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-215') (HOMO SAPIENS V-KAPPA ( IGKV3D-11*02 (90%) IGKJ1*01)(7.3.9) (1'-108')-HOMO SAPIENS IGKC*01 (109'-215')), DIMER (223-223'':226-226'')-BISDISULFIDE
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CNR1 (CANNABINOID RECEPTOR 1, CANN6, CNR)), HUMANIZED MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN HUMANIZED (1-444) (VH (HOMO SAPIENS IGHV1-69*02 (86.7%)-(IGHD)-IGHJ4*01 (90.9%)) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (CH1 (118-215), HINGE S10>P (225) (216-227), CH2 (228-337), CH3 (338-442), CHS (443-444)) (118-444)), (131-215')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-215') (VKAPPA (HOMO SAPIENS IGKV3D-11*02 (90.1%)-IGKJ1*01 (100%)) (7.3.9) (1'-108')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (204), V101 (192) (109'-215'))DIMER (223-223'':226-226'')-BISDISULFIDE
JNJ2463
JNJ-2463
NIMACIMAB [INN]
NIMACIMAB [USAN]
RYI018
RYI-018

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

NIMACIMAB

Synonyms and Mappings

Resources